TURBOVAS

This brand name is authorized in Nigeria.

Active ingredients

The drug TURBOVAS contains one active pharmaceutical ingredient (API):

1	Rosuvastatin UNII 83MVU38M7Q - ROSUVASTATIN CALCIUM
	Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles.
	Read more about Rosuvastatin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7724	Tablet	TURBOVAS 20 TABLETS TAB 20 mg 3x10	97 RNW-PP-299994 TURBOVAS 20 TABLETS ROSUVASTATIN 20MG Generic Name: Rosuvastatin 20mg. Excipients: 1. Tribasic Calcium Phosphate BP. 2. Microcrystalline Cellulose BP (Avicel PH 102) 3. Lactose BP (Pharmatose DCL 15) 4. Crospovidone BP Type-B (Polyplasdone-XL 10) 5. Magnesium Stearate BP B4-7724 Drugs Imported Products 3X10 POM 1 12/5/2022 MICRO NOVA PHARMACEUTICALS IND LTD, Plot 3, Billings Way, Oregun 81299901 solomonsemicrolabs@gmail.com MICRO LABS LIMITED UNIT III, 92, SIPCOT COMPLEX HOSUR 635 126 INDIA, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA07	Rosuvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7724